Maine’s Legislature Confronts the Unintended Consequences of Required Marijuana Testing, Before Those Consequences Even Happen

The Maine Legislature’s Joint Standing Committee on Veterans and Legal Affairs will consider a host of marijuana-related bills next Monday, January 27. Check all five of them out here. The one I want to focus on is LD 1545, An Act Regarding the Testing of Adult Use Marijuana and Marijuana Products because this bill tries to address what has been a serious problem in most states launching adult use programs: a shortage of testing labs and resulting bottlenecks in those products.

For starters, LD 1545 seeks to amend language in Title 28-B, governing adult use marijuana in Maine, which currently requires ALL adult use marijuana or marijuana products to be tested by a licensed lab before sale. So what’s the problem with this? There’s serious and well-founded concerns that Maine simply won’t have enough testing labs at least for the launch of the program. This will lead to bottlenecks and significant delays in selling products to consumers. LD 1545 addresses this by permitting any product that has been held by a testing lab for five days without being tested to be sold anyway, with a disclaimer that the product hasn’t been tested.

This seems like a straightforward solution to an anticipated problem, but it seems worth looking briefly at the experience of other states with testing bottlenecks and lab shortages.

California’s lab shortages and bottlenecks circa 2018 were the stuff legends are made of. Now, if anything, California seems to have overcompensated in response and has 27 licensed labs (which isn’t that many, considering the state’s population), none of which report being at full capacity. These labs are facing business problems of their own, with many customers not paying timely or not paying at all. Some suggest that this is a symptom of the broader problem that California’s illicit marijuana market remains dominant and may even be getting stronger.

Closer to home, a shortage of testing labs has been a problem for Massachusetts. As is expected for Maine, Massachusetts started off with only two licensed testing labs. Labs were reporting demand for up to 4,000 tests per day, though, within a year of the adult use program’s launch, the state’s Cannabis Control Commission was reporting that, even with two labs, wait times were down to just a couple of days.

It’s hard to know exactly how Maine’s testing laws will affect the adult use market until that market has really taken off. Certainly, any serious impediments to selling product quickly will encourage return to the black market. I’m sure this will be part of the discussion in the VLA committee on Monday. See you there!

Portland Considers Giving Some Preference to Minority Applicants for Marijuana Retail Licenses

The City of Portland is considering giving preference to minority applicants when distributing retail marijuana licenses. This came up at the City Council’s last committee meeting on the draft ordinance, and city staff cautioned that this could be difficult to administer. After this conversation, I thought it would be worth looking briefly at how this has played out in other jurisdictions. 

There is no question that America’s "war on drugs" and the crackdown on marijuana disproportionately impacted black Americans and other minorities. This sad history is the impetus for the proposal in Portland, and proposals/laws in other jurisdictions. Here are four examples of how this has played out:

• In Maryland, there was no preference for minorities originally, but then nearly all of the licenses were awarded to white people and the state decided to try again. It increased the total number of licenses, and said it would give minority-owned businesses (and some other demographics) slight preference. That plan doesn’t seem to be playing out as envisioned; it is dragging on and on and on, amid multiple lawsuits alleging bias in the licensing process. 
• The Ohio legislature created a racial quota requiring 15% of all licenses to grow, process, and sell marijuana to be awarded to minority-owned and -operated companies. But state judges have said that law is unconstitutional. 
• In Massachusetts, the Cannabis Control Commission is limiting certain types of licenses to “economic empowerment and social equity applicants” along with "microbusinesses."  These include social consumption and delivery licenses. Exclusivity is planned for a period of years. These categories of licenses haven’t been awarded yet, so we will see how that process plays out. 
• The marijuana legalization law in Illinois (for adult use) includes a variety of provisions meant to expand opportunities for people of color and those “disproportionately impacted” by the war on drugs. But some are questioning whether this law will meet its goals since the adult use market launches this month, and for at least the first half of 2020 the only participants will be existing medical marijuana dispensaries which are almost entirely white-owned. It is not yet clear how many of the 75 licenses awarded later this year will actually go to demographics disproportionately impacted by the war on drugs. 

Maine does not have any such law at the state level, so we will wait and see how the Portland City Council deals with this issue moving forward.

Maine’s Hemp Policies Remain Turbulent as the Legislature Reconvenes

The legislature is reconvening on hemp issues this coming Thursday, January 9. The Committee on Agriculture, Conservation and Forestry is considering a simple resolve "Directing the Department of Agriculture, Conservation and Forestry to Submit to the United States Secretary of Agriculture a Plan for Continued Implementation of the Maine Industrial Hemp Program." This resolve is self-explanatory; it will direct the Department to submit a plan to the USDA for hemp production which would finally bring Maine’s program in line with federal law. 

What this resolve doesn’t do is address a more pressing issue with Maine’s hemp policies at the moment: the continued crackdown on CBD products manufactured out-of-state. We’ve heard multiple reports of state inspectors telling retailers to sell whatever is on their shelves, but not to buy any more CBD products from outside Maine. The policy formally took effect on January 1 (though the original guidance issued by the State said December 1), and it remains to be seen how aggressive the crackdown will be, especially since a large portion of current CBD ingestible products on the shelves in Maine are from elsewhere.